News | January 15, 2014

ROI Awards Malolan Rajagopalan Grant to Develop Website, Mobile App to Track Radiotherapy Toxicity

January 15, 2014 — The Radiation Oncology Institute (ROI) has selected Malolan S. Rajagopalan, M.D., radiation oncology resident, University of Pittsburgh Cancer Institute, to receive a $20,000 grant for a project to compile best practices regarding the management of radiation therapy toxicity. Rajagopalan’s project proposal includes development of a website and mobile application that will give ROI the capability to continually update this material so that it will remain current. Combined, the website and mobile app will be comprehensive tools that will improve patient quality of life and treatment outcomes.
 
Rajagopalan and his team will develop the website and a mobile app, for Apple iOS phones and tablets, to allow physicians, nurses and physician assistants to quickly review and implement symptom management pathways and guidelines for patients and provide links to peer-reviewed literature and areas in need of further study. The site will provide comprehensive information, recommendations with evidence links and other published articles. The site will be structured to be a living document that selected experts will update. The mobile app will also include a drug prescription reference tailored for oncology, as well as a number of tools and references to guide clinicians on the go.
 
Rajagopalan’s team will form a multidisciplinary panel of radiation oncology specialists and various other fields such as palliative care and pulmonology to review all materials to ensure the quality and comprehensiveness of the information and resources provided. Each panel of approximately four to six members will include radiation oncologists from various institutions and, for diversity, at least one member who is not a radiation oncologist. The first two symptoms that will be addressed are the most prevalent side effects of radiation therapy: dermatitis and oral mucositis.
 
Together, the website and mobile app will compile and categorize both acute and late radiation symptom management strategies, and prioritize them by effectiveness and the levels of evidence that support them. Rajagopalan plans to unveil both for beta review and testing Sept. 14-17, 2014 at ASTRO’s 56th Annual Meeting in San Francisco.
 
“A multidisciplinary cancer treatment plan includes thorough consideration and accounting for the individual needs of each patient, particularly when treatment side effects significantly impact patient compliance and outcomes,” said ROI President Theodore Lawrence, M.D., Ph.D., FASTRO, and president, ROI. “We are excited that Rajagopalan’s project will provide us with the best approaches to mitigating adverse treatment effects and a platform that will permit us to continue to grow this valuable resource.”
 
For more information: www.roinstitute.org

Related Content

UCLA Study Offers Roadmap to Personalized Therapies for Sarcoma
News | Oncology Diagnostics | August 22, 2017
A new UCLA study is the first to identify patient and tumor characteristics that predict the successful creation of...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
Sponsored Content | Videos | Proton Therapy | August 21, 2017
Mark Pankuch, Ph.D., director of medical physics at the Northwestern Medicine Chicago Proton Center, discusses the cl
Summit Cancer Center-Boise Treats First Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | August 21, 2017
Accuray Inc. and the Summit Cancer Center-Boise announced that the center is now treating patients with the Radixact...
MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Virtual Phantoms Inc. Releases VirtualDose-IR
Technology | Radiation Dose Management | August 07, 2017
Virtual Phantoms Inc. announced the release of VirtualDoseIR, a tool for assessing organ dose from interventional...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Overlay Init